首页 | 本学科首页   官方微博 | 高级检索  
检索        


Ultrastructural Immuno-localization of Synthetic Prion Protein Peptide Antibodies in 87V Murine Scrapie
Institution:1. Bay Pines VA Healthcare System, Research and Development, 151, Bldg. 22 Rm. 123, 10000 Bay Pines Blvd, Bay Pines, FL 33744, USA;2. Department of Molecular Medicine, USF College of Medicine, 12901 Bruce B. Downs Blvd, MDC 7, Tampa, FL 33612, USA;3. NeuroStructural Analytics, Inc., Columbus, OH, USA;4. Center for Aging and Brain Repair, Department of Neurosurgery and Brain Repair, University of South Florida Morsani College of Medicine, 2 Tampa General Circle, Tampa, FL 33606, USA;5. VA New Jersey Health Care System, Research & Development, Mailstop 15, Bldg. 16, Rm. 16-176, 385 Tremont Ave, East Orange, NJ 07018, USA;6. Department of Pharmacology, Physiology & Neuroscience, Rutgers- New Jersey Medical School, 185 South Orange Ave., Newark, NJ 07101, USA;7. Department of Anatomy and Anthropology, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel;8. Department of Psychiatry, Tel Aviv Sourasky Medical Center, Tel Aviv 64239, Israel;9. Department of Psychiatry, Tel Aviv University Sackler Faculty of Medicine, Tel Aviv 64239, Israel;10. Sagol School of Neuroscience, Tel Aviv University, Tel Aviv 69978, Israel;11. Dr. Miriam and Sheldon G. Adelson Chair, Center for the Biology of Addictive Diseases, Tel Aviv University, Tel Aviv 69978, Israel;2. CNS-Campus Neurológico Sénior, Torres Vedras, Portugal;3. Federal State Budgetary Educational Institution of Higher Education “N.I. Pirogov Russian National Research Medical University” of the Ministry of Healthcare of the Russian Federation, Moscow, Russia;4. National Parkinson Foundation International Centre of Excellence, Kings College and Kings College Hospital, London, United Kingdom;5. Radboud University Medical Centre, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands;1. Vanderbilt University School of Medicine, Nashville, TN, United States;2. Department of Neurological Surgery, Vanderbilt University Medical Center, Section of Surgical Sciences, Nashville, TN United States;3. Division of Acute Care Surgery, Department of Surgery, Section of Surgical Sciences, Vanderbilt University Medical Center, Nashville, TN United States;4. Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN, United States;5. Department of Hearing and Speech Sciences, Vanderbilt University Medical Center, Nashville, TN, United States;6. Center for Health Services Research, Vanderbilt University Medical Center, Nashville, TN, United States;7. Surgical Services, Geriatric Research Education and Clinical Centers, Tennessee Valley Healthcare System, United States Department of Veterans Affairs, Nashville, TN, United States;8. Critical Illness, Brain Dysfunction, and Survivorship (CIBS) Center, Vanderbilt Brain Institute, United States
Abstract:Disease specific forms of a host encoded cell surface sialoglycoprotein called prion protein (PrP) accumulate during the incubation period of the transmissible spongiform encephalopathies. A 33–35 kDa disease specific form of PrP is partially resistant to protease digestion whereas the normal form of PrP can be completely digested. Proteinase K digestion of the murine disease specific form of PrP produces diverse forms of low molecular weight PrP, some of which are N-terminally truncated at amino acid residue 49 or 57 within the octapeptide repeat segment. Amyloid plaques are a pathological feature of many of the transmissible spongiform encephalopathies and are composed of PrP. Using synthetic peptide antibodies to the N-terminus of PrP (which is not present in truncated disease specific PrP) and antibodies to the protease resistant fraction of PrP we have immunostained plaques and pre-amyloid deposits in the brains of mice, experimentally infected with the 87V strain of scrapie, for examination by light and electron microscopy. Classical fibrillar amyloid deposits in plaques as well as pre-amyloid deposits were both immunostained by antibodies to the N-terminus of PrP and to the protease resistant core of the PrP molecule. This suggests that both N-terminal and core amino acid residues are present in disease specific PrP released from scrapie infected cells in vivo. The results also suggest that N-terminal truncation of PrP may not be essential for formation of amyloid fibrils.
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号